An in vivo systematic genetic analysis of tumour progression in Drosophila -
RNAi line: 9416

   Metastasis is the leading cause of death for cancer patients.
   Consequently it is imperative that we improve our understanding of the
   molecular mechanisms that underlie progression of tumour growth towards
   malignancy. Advances in genome characterisation technologies have been
   very successful in identifying commonly mutated or misregulated genes
   in a variety of human cancers. A major challenge however is the
   translation of these findings to new biological insight due to the
   difficulty in evaluating whether these candidate genes drive tumour
   progression. Using the genetic amenability of Drosophila melanogaster
   we generated tumours with specific genotypes in the living animal and
   carried out a detailed systematic loss-of-function analysis to identify
   numerous conserved genes that enhance or suppress epithelial tumour
   progression. This enabled the discovery of functional cooperative
   regulators of invasion and the establishment of a network of conserved
   ‘invasion suppressors’.

   RNAi line: 9416 (III)
   Source: VDRC
   Name: eIF-2beta (2)
   Full name: eukaryotic translation initiation factor 2 subunit beta
   Also known as: eIF2β, eIF-2β, eIF-2, elF2β
   Annotation symbol: CG4153
   FlyBase ID: FBgn0004926
   File naming convention: File names typically contain representations of
   date (DDMMYY), RNAi Line, Animal Number and, in some cases, window (to
   accommodate larger samples that require multiple image stacks)

   Included files: 051214_lgl_9416_An11_combined.tif
   101214b_Lgl9416An19_combined.tif 110215_Lgl9416An6_combined.tif
   111214_An12_9416_w_combined.tif 120215_An2_9416_w_combined.tif
   170215_Lgl9416An1_combined.tif